Abstract
Modern drug discovery and design approaches rely heavily on high-throughput methods and state-of-the-art infrastructures with robotic facilities and sophisticated platforms. However, the anticipated research output that would eventually lead to new drugs with minimal or no side effects to the market has not been achieved. Despite the vast amount of information generated, very little is converted to knowledge and even less is capitalized for cross-discipline research actions. Therefore, the need for re-launching rational approaches has become apparent. Here we present an overview of the new trends in rational drug design using integrative structural biology with emphasis on X-ray protein crystallography and small molecules as ligands. With the aim to increase researchers’ awareness on the available possibilities to perform front line research, we also underline the benefits and enhanced prospects offered to the scientific community, through access to research infrastructures.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 3D:
-
Three dimensional
- DLS:
-
Dynamic light scattering
- DMSO:
-
Dimethyl sulfoxide
- EM:
-
Electron microscopy
- HPLC:
-
High-performance liquid chromatography
- HR-MS:
-
High-resolution mass spectrometry
- MALLS:
-
Multi-angle laser light scattering
- NMR:
-
Nuclear magnetic resonance
- RI:
-
Research infrastructure
- SAXS:
-
Small-angle X-ray scattering
- SEC:
-
Size exclusion chromatography
- SRS:
-
Synchrotron radiation source
References
Berman HM (2008) The protein data bank: a historical perspective. Acta Crystallogr A 64(Pt 1):88–95. https://doi.org/10.1107/S0108767307035623
Scannell JW, Blanckley A, Boldon H et al (2012) Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov 11(3):191–200. https://doi.org/10.1038/nrd3681
Scannell JW, Bosley J (2016) When quality beats quantity: decision theory, drug discovery, and the reproducibility crisis. PLoS One 11(2):e0147215. https://doi.org/10.1371/journal.pone.0147215
Manglik A, Lin H, Aryal DK et al (2016) Structure-based discovery of opioid analgesics with reduced side effects. Nature 537(7619):185–190. https://doi.org/10.1038/nature19112
Wacker D, Wang S, McCorvy JD et al (2017) Crystal structure of an LSD-bound human serotonin receptor. Cell 168(3):377–389.e12. https://doi.org/10.1016/j.cell.2016.12.033
Dormitzer PR, Grandi G, Rappuoli R (2012) Structural vaccinology starts to deliver. Nat Rev Microbiol 10(12):807–813. https://doi.org/10.1038/nrmicro2893
Gourlay L, Peri C, Bolognesi M et al (2017) Structure and computation in immunoreagent design: from diagnostics to vaccines. Trends Biotechnol 35(12):1208–1220. https://doi.org/10.1016/j.tibtech.2017.06.018
Khan FI, Lan D, Durrani R et al (2017) The lid domain in lipases: structural and functional determinant of enzymatic properties. Front Bioeng Biotechnol 5:1–13. https://doi.org/10.3389/fbioe.2017.00016
Jensen MBV, Horsfall LE, Wardrope C et al (2016) Characterisation of a new family of carboxyl esterases with an OsmC domain. PLoS One 11(11):e0166128. https://doi.org/10.1371/journal.pone.0166128
Scholz J, Besir H, Strasser C et al (2013) A new method to customize protein expression vectors for fast, efficient and background free parallel cloning. BMC Biotechnol 13(1):12. https://doi.org/10.1186/1472-6750-13-12
Owens RJ (ed) (2015) Structural proteomics: high-throughput methods. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4939-2230-7
Singh A, Upadhyay V, Upadhyay AK et al (2015) Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process. Microb Cell Factories 14:2–10. https://doi.org/10.1186/s12934-015-0222-8
Malissard M, Berger EG (2001) Improving solubility of catalytic domain of human beta-1,4-galactosyltransferase 1 through rationally designed amino acid replacements. Eur J Biochem 268(15):4352–4358. https://doi.org/10.1046/j.1432-1327.2001.02357.x
Janson J-C (ed) (2011) Protein purification: principles, high resolution methods and applications. Wiley, Hoboken. https://doi.org/10.1002/9780470939932
Gasteiger E, Hoogland C, Gattiker A et al (2005) Protein identification and analysis tools on the ExPASy server. In: Walker J (ed) The proteomics protocols handbook. Humana Press, Totowa, NJ
Gupta R, Brunak S (2002) Prediction of glycosylation across the human proteome and the correlation to protein function. Pac Symp Biocomput 7:310–322
Steentoft C, Vakhrushev SY, Joshi HJ et al (2013) Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology. EMBO J 32(10):1478–1488. https://doi.org/10.1038/emboj.2013.79
Kimple ME, Brill AL, Pasker RL (2015) Overview of affinity tags for protein purification. Curr Protoc Protein Sci Unit-9.9:1–26. https://doi.org/10.1002/0471140864.ps0909s73
Sahin E, Roberts CJ (2012) Size-exclusion chromatography with multi-angle light scattering for elucidating protein aggregation mechanisms. In: Voynov V, Caravella J (eds) Therapeutic proteins. Methods in molecular biology (methods and protocols), vol 899. Humana Press, Totowa, NJ
Greenfield NJ (2006) Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc 1(6):2876–2890. https://doi.org/10.1038/nprot.2006.202
Macchi P (2011) Cryo-crystallography: diffraction at low temperature and more. In: Rissanen K (ed) Advanced X-ray crystallography. Topics in current chemistry, vol 315. Springer, Berlin, Heidelberg
Krojer T, Pike ACW, Von Delft F (2013) Squeezing the most from every crystal: the fine details of data collection. Acta Crystallogr Sect D Biol Crystallogr 69:1303–1313. https://doi.org/10.1107/S0907444913013280
Kabsch W (2010) XDS. Acta Crystallogr D Biol Crystallogr 66(Pt2):125–132. https://doi.org/10.1107/S0907444909047337
Leslie AGW, Powell HR (2007) Processing diffraction data with mosflm. In: Read RJ, Sussman JL (eds) Evolving methods for macromolecular crystallography. NATO Science Series, vol 245. Springer, Dordrecht
Winn MD, Ballard CC, Cowtan KD et al (2011) Overview of the CCP4 suite and current developments. Acta Crystallogr Sect D Biol Crystallogr 67(Pt.4):235–242. https://doi.org/10.1107/S0907444910045749
Navaza J, Saludjian P (1997) AMoRe: an automated molecular replacement program package. Methods Enzymol 276:581–594. https://doi.org/10.1016/S0076-6879(97)76079-8
McCoy AJ, Grosse-Kunstleve RW, Adams PD et al (2007) Phaser crystallographic software. J Appl Crystallogr 40(Pt.4):658–674. https://doi.org/10.1107/S0021889807021206
Vagin A, Teplyakov A (1997) MOLREP: an automated program for molecular replacement. J Appl Crystallogr 30:1022–1025. https://doi.org/10.1107/S0021889897006766
Adams PD, Afonine PV, Bunkóczi G et al (2010) PHENIX: a comprehensive python-based system for macromolecular structure solution. Acta Crystallogr Sect D Biol Crystallogr 66(Pt.2):213–221. https://doi.org/10.1107/S0907444909052925
Emsley P, Lohkamp B, Scott WG et al (2010) Features and development of coot. Acta Crystallogr Sect D Biol Crystallogr 66(Pt.4):486–501. https://doi.org/10.1107/S0907444910007493
Murshudov GN, Vagin AA, Dodson EJ (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53(Pt.3):240–255. https://doi.org/10.1107/S0907444996012255
Murshudov GN, Skubák P, Lebedev AA et al (2011) REFMAC 5 for the refinement of macromolecular crystal structures. Acta Crystallogr Sect D Biol Crystallogr 67:355–367. https://doi.org/10.1107/S0907444911001314
Chen VB, Arendall WB, Headd JJ et al (2010) MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr Sect D Biol Crystallogr 66(Pt.1):12–21. https://doi.org/10.1107/S0907444909042073
Hanwell MD, Curtis DE, Lonie DC et al (2012) Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. Aust J Chem 4(1):17. https://doi.org/10.1186/1758-2946-4-17
Schüttelkopf AW, Van Aalten DMF (2004) PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr Sect D Biol Crystallogr 60(Pt.8):1355–1363. https://doi.org/10.1107/S0907444904011679
Laskowski RA, Swindells MB (2011) LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model 51(10):2778–2786. https://doi.org/10.1021/ci200227u
Pettersen EF, Goddard TD, Huang CC et al (2004) UCSF chimera—a visualization system for exploratory research and analysis. J Comput Chem 25(13):1605–1612. https://doi.org/10.1002/jcc.20084
Bissantz C, Kuhn B, Stahl M (2010) A medicinal chemist’s guide to molecular interactions. J Med Chem 53(14):5061–5084. https://doi.org/10.1021/jm100112j
Meyer EA, Castellano RK, Diederich F (2003) Interactions with aromatic rings in chemical and biological recognition. Angew Chem Int Ed 42(11):1210–1250. https://doi.org/10.1002/anie.200390319
Le Guilloux V, Schmidtke P, Tuffery P (2009) Fpocket: an open source platform for ligand pocket detection. BMC Bioinformatics 10:168. https://doi.org/10.1186/1471-2105-10-168
Dundas J, Ouyang Z, Tseng J et al (2006) CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acids Res 34:W116–W118. https://doi.org/10.1093/nar/gkl282
Stank A, Kokh DB, Horn M et al (2017) TRAPP webserver: predicting protein binding site flexibility and detecting transient binding pockets. Nucleic Acids Res 45(W1):W325–W330. https://doi.org/10.1093/nar/gkx277
Porter CT (2004) The catalytic site atlas: a resource of catalytic sites and residues identified in enzymes using structural data. Nucleic Acids Res 32:129D–133D. https://doi.org/10.1093/nar/gkh028
Torrance JW, Bartlett GJ, Porter CT et al (2005) Using a library of structural templates to recognise catalytic sites and explore their evolution in homologous families. J Mol Biol 347(3):565–581. https://doi.org/10.1016/j.jmb.2005.01.044
Van Linden OPJ, Kooistra AJ, Leurs R et al (2014) KLIFS: a knowledge-based structural database to navigate kinase-ligand interaction space. J Med Chem 57(2):249–277. https://doi.org/10.1021/jm400378w
Kooistra AJ, Kanev GK, Van Linden OPJ et al (2016) KLIFS: a structural kinase-ligand interaction database. Nucleic Acids Res 44:D365–D371. https://doi.org/10.1093/nar/gkv1082
Hendlich M, Bergner A, Günther J et al (2003) Relibase: design and development of a database for comprehensive analysis of protein-ligand interactions. J Mol Biol 326(2):607–620. https://doi.org/10.1016/S0022-2836(02)01408-0
Verma R, Mitchell-Koch K (2017) In silico studies of small molecule interactions with enzymes reveal aspects of catalytic function. Catalysts 7(7):212. https://doi.org/10.3390/catal7070212
Lu Y, Wang R, Yang CY et al (2007) Analysis of ligand-bound water molecules in high-resolution crystal structures of protein-ligand complexes. J Chem Inf Model 47(2):668–675. https://doi.org/10.1021/ci6003527
Spyrakis F, Ahmed MH, Bayden AS et al (2017) The roles of water in the protein matrix: a largely untapped resource for drug discovery. J Med Chem 60(16):6781–6828. https://doi.org/10.1021/acs.jmedchem.7b00057
Mavrokefalos N, Myrianthopoulos V, Chajistamatiou AS et al (2015) Discovery of the glycogen phosphorylase-modulating activity of a resveratrol glucoside by using a virtual screening protocol optimized for solvation effects. Planta Med 81(6):507–516. https://doi.org/10.1055/s-0035-1545910
Tan KP, Nguyen TB, Patel S et al (2013) Depth: a web server to compute depth, cavity sizes, detect potential small-molecule ligand-binding cavities and predict the pKa of ionizable residues in proteins. Nucleic Acids Res 41:W314–W321. https://doi.org/10.1093/nar/gkt503
Kelly LA, Mezulis S, Yates C et al (2015) The Phyre2 web portal for protein modelling, prediction, and analysis. Nat Protoc 10(6):845–858. https://doi.org/10.1038/nprot.2015.053
Zhang Y (2008) I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9:40. https://doi.org/10.1186/1471-2105-9-40
Biasini M, Bienert S, Waterhouse A et al (2014) SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res 42:W252–W258. https://doi.org/10.1093/nar/gku340
Kim DE, Chivian D, Baker D (2004) Protein structure prediction and analysis using the Robetta server. Nucleic Acids Res 32:526–531. https://doi.org/10.1093/nar/gkh468
Koehn J, Hunt I (2009) High-throughput protein production (HTPP): a review of enabling technologies to expedite protein production. In: Doyle SA (ed) High throughput protein expression and purification. Methods in molecular biology, vol 498. Humana Press, Totowa, NJ
McPherson A, Gavira JA (2014) Introduction to protein crystallization. Acta Crystallogr Sect F Structural Biol Commun 70(Pt.1):2–20. https://doi.org/10.1107/S2053230X13033141
Mamais M, Degli Esposti A, Kouloumoundra V et al (2017) A new potent inhibitor of glycogen phosphorylase reveals the basicity of the catalytic site. Chem—A Eur J 23(37):8800–8805. https://doi.org/10.1002/chem.201701591
Irwin JJ, Shoichet BK (2005) ZINC—a free database of commercially available compounds for virtual screening. J Chem Inf Model 45(1):177–182. https://doi.org/10.1021/ci049714+
Blundell TL, Jhoti H, Abell C (2002) High-throughput crystallography for lead discovery in drug design. Nat Rev Drug Discov 1(1):45–54. https://doi.org/10.1038/nrd706
Cavasotto CN (ed) (2017) In silico drug discovery and design theory, methods, challenges, and applications. CRC Press, Boca Raton
de Vrueh RLA, Crommelin DJA (2017) Reflections on the future of pharmaceutical public-private partnerships: from input to impact. Pharm Res 34(10):1985–1999. https://doi.org/10.1007/s11095-017-2192-5
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Chegkazi, M.S., Mamais, M., Sotiropoulou, A.I., Chrysina, E.D. (2018). Rational Drug Design Using Integrative Structural Biology. In: Mavromoustakos, T., Kellici, T. (eds) Rational Drug Design. Methods in Molecular Biology, vol 1824. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8630-9_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8630-9_6
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8629-3
Online ISBN: 978-1-4939-8630-9
eBook Packages: Springer Protocols